These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 9123176)
21. Prolonged survival of rat cardiac allografts induced by intrathymic injection of donor bone marrow cells. Matsuura T; Hara Y; Imanishi M; Kanda H; Kurita T Transplant Proc; 1993 Dec; 25(6):3283-5. PubMed ID: 8266544 [No Abstract] [Full Text] [Related]
23. Indirect allorecognition is involved in both acute and chronic allograft rejection. Fluck N; Witzke O; Morris PJ; Wood KJ Transplant Proc; 1999; 31(1-2):842-3. PubMed ID: 10083366 [No Abstract] [Full Text] [Related]
24. Effects of intrathymic tolerance on mouse heart and skin allograft acceptance. Tu Y; Arima T; Flye MW Transplant Proc; 1997; 29(1-2):1063-4. PubMed ID: 9123200 [No Abstract] [Full Text] [Related]
25. Soluble donor MHC class I gene therapy prevents accelerated heart allograft rejection in actively sensitized rat recipients. Tange S; Graeb C; Scherer MN; Frank E; Jauch K; Geissler EK Transplant Proc; 2001; 33(1-2):579-80. PubMed ID: 11266966 [No Abstract] [Full Text] [Related]
26. Differences in cellular mechanisms between heart and skin graft rejection by in vitro and in vivo analyses. Yamamoto T; Yamaguchi J; Gu W; Ishii T; Hashimoto T; Usui K; Mizoe A; Azuma T; Fujioka H; Furui J; Kanematsu T Transplant Proc; 1998 Nov; 30(7):3854. PubMed ID: 9838686 [No Abstract] [Full Text] [Related]
27. CD28-B7 T-cell co-stimulatory blockade potentiates the effects of intrathymic immunomodulation in sensitized graft recipients. Stadlbauer TH; Schaub M; Korom S; Onodera K; Sayegh MH; Kupiec-Weglinski JW Transplantation; 1997 Dec; 64(12):1816-22. PubMed ID: 9422425 [TBL] [Abstract][Full Text] [Related]
28. Different in vivo tolerogenicity of MHC class I peptides. Fändrich F; Zhu X; Schröder J; Dresske B; Henne-Bruns D; Oswald H; Zavazava N J Leukoc Biol; 1999 Jan; 65(1):16-27. PubMed ID: 9886242 [TBL] [Abstract][Full Text] [Related]
29. Effects of a combined antigen-cyclosporine regimen in four transplantation models. Didlake R; Kakazaki K; Yoshimura N; Merrell R; Kahan BD Transplant Proc; 1987 Feb; 19(1 Pt 2):1281-3. PubMed ID: 3152626 [No Abstract] [Full Text] [Related]
30. CD4-targeted therapy induces "infectious" tolerance to cardiac allografts in sensitized rat recipients. Onodera K; Lehmann M; Volk HD; Sayegh MH; Kupiec-Weglinski JW Transplant Proc; 1997 May; 29(3):1907-8. PubMed ID: 9142316 [No Abstract] [Full Text] [Related]
31. Induction of specific unresponsiveness to rat cardiac allografts by pretreatment with intrathymic donor major histocompatibility complex class I antigens. Oluwole SF; Chowdhury NC; Fawwaz R; James T; Hardy MA Transplant Proc; 1993 Feb; 25(1 Pt 1):299-300. PubMed ID: 8438308 [No Abstract] [Full Text] [Related]
32. Indirect allorecognition of donor class I and II major histocompatibility complex peptides promotes the development of transplant vasculopathy. Womer KL; Stone JR; Murphy B; Chandraker A; Sayegh MH J Am Soc Nephrol; 2001 Nov; 12(11):2500-2506. PubMed ID: 11675428 [TBL] [Abstract][Full Text] [Related]
33. Induction of tolerance to islet allografts in the high responder rat by intrathymic inoculation of soluble alloantigens. Fiedor P; Jin MX; Hardy MA; Oluwole SF Transplant Proc; 1997; 29(1-2):764. PubMed ID: 9123515 [No Abstract] [Full Text] [Related]
34. Endothelial cell antigens associated with accelerated cardiac graft rejection in the rat. Yasunaga C; Cramer DV; Tuso PJ; Fujioka H; Barnett M; Yanaga K; Sugimachi K; Makowka L Transplant Proc; 1995 Feb; 27(1):495-6. PubMed ID: 7879075 [No Abstract] [Full Text] [Related]
35. Tolerance induction to cardiac allografts by sequential intrathymic inoculation of disparate alloantigens. Shimomura K; Hardy MA; Oluwole SF Transplant Proc; 1996 Jun; 28(3):1283-4. PubMed ID: 8658661 [No Abstract] [Full Text] [Related]
36. Transplantation tolerance to rat cardiac and islet allografts by posttransplant intrathymic inoculation of soluble alloantigens. Ohajekwe OA; Chowdhury NC; Fiedor PS; Hardy MA; Oluwole SF Transplantation; 1995 Nov; 60(10):1139-43. PubMed ID: 7482722 [TBL] [Abstract][Full Text] [Related]
37. Induction of tolerance in rat cardiac allograft model by intrathymic injection of donor bone marrow cells. Ito A; Ito T; Kamiike W; Nozaki S; Uchikoshi F; Tanaka T; Kuhara A; Moriguchi A; Miyata M; Nakata S Transplant Proc; 1995 Apr; 27(2):1607-8. PubMed ID: 7536974 [No Abstract] [Full Text] [Related]
38. Development of tolerance in a chronic rejection model. Tullius SG; Nieminen M; Bechstein WO; Jonas S; Rayes N; Qun Y; Volk HD; Neuhaus P Transplant Proc; 1998 Jun; 30(4):1075-6. PubMed ID: 9636436 [No Abstract] [Full Text] [Related]
39. The role of CD30 in skin and heart allograft rejection in the mouse. Beckmann J; Kurts C; Klebba I; Bayer B; Klempnauer J; Hoffmann MW Transplant Proc; 2001; 33(1-2):140-1. PubMed ID: 11266747 [No Abstract] [Full Text] [Related]
40. The alloantibody network following intrathymic immunomodulation of sensitized rat recipients of cardiac allografts. Binder J; Hancock WW; Watschinger B; Wasowska B; Sayegh MH; Kupiec-Weglinski JW Transplantation; 1995 Feb; 59(4):590-7. PubMed ID: 7878763 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]